Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.71 per share which met the analyst consensus estimate. This is a 7.79 percent decrease over earnings of $0.77 per share from the same period last year. The company reported quarterly sales of $3.88 billion which missed the analyst consensus estimate of $3.93 billion by 1.17 percent. This is a 5.27 percent decrease over sales of $4.10 billion the same period last year.
Teva Pharmaceutical Indus Q4 EPS $0.71, Inline, Sales $3.88B Miss $3.93B Estimate
Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.71 per share which met the analyst consensus estimate. This is a 7.79 percent decrease over earnings of $0.77 per share from the same period last
Related Posts
Overview Of Value Stocks In The Financial Services Sector
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices…
Jeep’s All-Electric Wagoneer S Beats Tesla Model Y Performance In Acceleration Test, Lags Behind Model X
Stellantis NV's Jeep on Wednesday released a video of its upcoming all-electric Wagoneer S SUV and raced it against Tesla Inc's Model Y Performance to prove its faster acceleration.
Wedbush Upgrades Skyline Champion to Outperform, Announces $70 Price Target
Wedbush analyst Jay McCanless upgrades Skyline Champion (NYSE:SKY) from Neutral to Outperform and announces $70 price target.